Patents by Inventor Shelly Hester

Shelly Hester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250114419
    Abstract: Compositions for promoting intestinal health are disclosed and described. In one example, the composition can include a combination of cyanidins and delphinidins, in an amount sufficient to treat intestinal hyperpermeability. In a further example, the composition can further comprise a prebiotic blend and fructooligosaccharides. Further presented herein, is a method of treating a condition or disorder related to gastrointestinal health in a subject. In one example, the method can include maximizing tight junction integrity in epithelial cells of gastrointestinal tract of the subject.
    Type: Application
    Filed: August 12, 2024
    Publication date: April 10, 2025
    Inventors: Angela Mastaloudis, Steven M. Wood, Shelly Hester, Mark Bartlett
  • Publication number: 20220322719
    Abstract: Compositions for promoting intestinal health are disclosed and described. In one example, the composition can include a combination of cyanidins and delphinidins, in an amount sufficient to treat intestinal hyperpermeability. In a further example, the composition can further comprise a prebiotic blend and fructooligosaccharides. Further presented herein, is a method of treating a condition or disorder related to gastrointestinal health in a subject. In one example, the method can include maximizing tight junction integrity in epithelial cells of gastrointestinal tract of the subject.
    Type: Application
    Filed: March 15, 2022
    Publication date: October 13, 2022
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steven M. Wood, Shelly Hester, Mark Bartlett
  • Publication number: 20190255134
    Abstract: Compositions for promoting intestinal health are disclosed and described. In one example, the composition can include a combination of cyanidins and delphinidins, in an amount sufficient to treat intestinal hyperpermeability. In a further example, the composition can further comprise a prebiotic blend and fructooligosaccharides. Further presented herein, is a method of treating a condition or disorder related to gastrointestinal health in a subject. In one example, the method can include maximizing tight junction integrity in epithelial cells of gastrointestinal tract of the subject.
    Type: Application
    Filed: October 27, 2016
    Publication date: August 22, 2019
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steven M. Wood, Shelly Hester
  • Publication number: 20180055802
    Abstract: An oral formulation can include an omega-3 fatty acid, a stilbenoid, a flavonoid, and vitamin D, each present in an amount and weight ratio that causes the formulation to mimic a gene expression profile of caloric restriction in a tissue of a subject, when administered to the subject in a therapeutically effective amount. The oral formulation can also be used in a method of mimicking a caloric restriction gene expression profile in a tissue of a subject.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 1, 2018
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steven M. Wood, Mark Bartlett, Shelly Hester